ClariTrial | Search Clinical Trials

Status

Phase

139,773 results for “Cancer”

Page 1 of 9319

UNKNOWN

Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity.

N/ASquamous Cell Carcinoma of the OralClinically Node-Negative and Radiology

PET-CT

University Hospital, Grenoble40 participants1 site · FranceCompletes Aug 2021

Compare CT.gov Full analysis →

Completed

MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer

N/AColorectal Neoplasms

MicroOrganoSphere (MOS) drug screen

Xilis, Inc.46 participants7 sites · United StatesCompletes Nov 2023

Compare CT.gov Full analysis →

Completed

Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing

N/ACarcinomaNon-small-cell Lung CancerLung Neoplasm

Peking University People's Hospital100 participants1 site · ChinaCompletes Jul 2018

Compare CT.gov Full analysis →

Completed

Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer

Phase 2Colorectal Cancer

FOLFIRI regimenfluorouracilirinotecan hydrochloride+4 more

Cardiff University111 participants4 sites · United KingdomCompletes Jul 2011

Compare CT.gov Full analysis →

UNKNOWN

Manchester Lung Health Study

N/ALung Cancer

Lung Cancer ScreeningBiomarkers

Manchester University NHS Foundation Trust9,730 participants1 site · United KingdomCompletes Aug 2024

Compare CT.gov Full analysis →

Recruiting

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Phase 2Unresectable Melanoma

Prebiotic Food-Enriched Diet

M.D. Anderson Cancer Center75 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls

N/APolycystic Ovary SyndromeInsulin Resistance

Metformin

Aga Khan University110 participants1 site · PakistanCompletes May 2025

Compare CT.gov Full analysis →

Completed

Results posted

Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Phase 3Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia

Calaspargase Pegol-mknlCyclophosphamideCytarabine+12 more

Children's Oncology Group166 participants27 sites · United StatesCompletes Feb 2011

Compare CT.gov Full analysis →

Terminated

Results posted

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Phase 1Phase 2High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor

PazopanibPazopanib HydrochlorideSapanisertib

National Cancer Institute (NCI)151 participants460 sites · United StatesCompletes Dec 2018

Compare CT.gov Full analysis →

Completed

Results posted

Pomalidomide for Kaposi Sarcoma in People With or Without HIV

Phase 1Phase 2Kaposi SarcomaSarcoma, Kaposi

Pomalidomide

National Cancer Institute (NCI)28 participants1 site · United StatesCompletes May 2022

Compare CT.gov Full analysis →

UNKNOWN

De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

N/ANSCLC

Severance Hospital155 participantsCompletes Sep 2014

Compare CT.gov Full analysis →

UNKNOWN

Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma

Phase 2Nasopharyngeal Neoplasms

ToripalimabAlbumin-bound PaclitaxelCisplatin+1 more

First People's Hospital of Foshan50 participantsCompletes Dec 2023

Compare CT.gov Full analysis →

Not Yet Recruiting

The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

N/AGastric CancerGastroesophageal Junction Adenocarcinoma

Iparomlimab/Tuvonralimab (anti PD-1/CTLA-4) combined with albumin-bound paclitaxel

Qingxia Li30 participants1 site · ChinaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Cognition and QoL After Thyroid Surgery

N/AThyroid NoduleThyroid CancerCognitive Decline

Karolinska University Hospital320 participants1 site · SwedenCompletes Nov 2023

Compare CT.gov Full analysis →

Completed

Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma

N/AMultiple Myeloma

Economic evaluation

Institut Paoli-Calmettes60 participants1 site · FranceCompletes Dec 2015

Compare CT.gov Full analysis →

1–15 of 139,773

Explore/Cancer

Status

Phase

139,773 results for “Cancer”

Page 1 of 9319

UNKNOWN

Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity.

N/ASquamous Cell Carcinoma of the OralClinically Node-Negative and Radiology

PET-CT

University Hospital, Grenoble40 participants1 site · FranceCompletes Aug 2021

Compare CT.gov Full analysis →

Completed

MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer

N/AColorectal Neoplasms

MicroOrganoSphere (MOS) drug screen

Xilis, Inc.46 participants7 sites · United StatesCompletes Nov 2023

Compare CT.gov Full analysis →

Completed

Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing

N/ACarcinomaNon-small-cell Lung CancerLung Neoplasm

Peking University People's Hospital100 participants1 site · ChinaCompletes Jul 2018

Compare CT.gov Full analysis →

Completed

Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer

Phase 2Colorectal Cancer

FOLFIRI regimenfluorouracilirinotecan hydrochloride+4 more

Cardiff University111 participants4 sites · United KingdomCompletes Jul 2011

Compare CT.gov Full analysis →

UNKNOWN

Manchester Lung Health Study

N/ALung Cancer

Lung Cancer ScreeningBiomarkers

Manchester University NHS Foundation Trust9,730 participants1 site · United KingdomCompletes Aug 2024

Compare CT.gov Full analysis →

Recruiting

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Phase 2Unresectable Melanoma

Prebiotic Food-Enriched Diet

M.D. Anderson Cancer Center75 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Completed

Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls

N/APolycystic Ovary SyndromeInsulin Resistance

Metformin

Aga Khan University110 participants1 site · PakistanCompletes May 2025

Compare CT.gov Full analysis →

Completed

Results posted

Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Phase 3Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia

Calaspargase Pegol-mknlCyclophosphamideCytarabine+12 more

Children's Oncology Group166 participants27 sites · United StatesCompletes Feb 2011

Compare CT.gov Full analysis →

Terminated

Results posted

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Phase 1Phase 2High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor

PazopanibPazopanib HydrochlorideSapanisertib

National Cancer Institute (NCI)151 participants460 sites · United StatesCompletes Dec 2018

Compare CT.gov Full analysis →

Completed

Results posted

Pomalidomide for Kaposi Sarcoma in People With or Without HIV

Phase 1Phase 2Kaposi SarcomaSarcoma, Kaposi

Pomalidomide

National Cancer Institute (NCI)28 participants1 site · United StatesCompletes May 2022

Compare CT.gov Full analysis →

UNKNOWN

De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

N/ANSCLC

Severance Hospital155 participantsCompletes Sep 2014

Compare CT.gov Full analysis →

UNKNOWN

Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma

Phase 2Nasopharyngeal Neoplasms

ToripalimabAlbumin-bound PaclitaxelCisplatin+1 more

First People's Hospital of Foshan50 participantsCompletes Dec 2023

Compare CT.gov Full analysis →

Not Yet Recruiting

N/AGastric CancerGastroesophageal Junction Adenocarcinoma

Iparomlimab/Tuvonralimab (anti PD-1/CTLA-4) combined with albumin-bound paclitaxel

Qingxia Li30 participants1 site · ChinaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Cognition and QoL After Thyroid Surgery

N/AThyroid NoduleThyroid CancerCognitive Decline

Karolinska University Hospital320 participants1 site · SwedenCompletes Nov 2023

Compare CT.gov Full analysis →

Completed

Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma

N/AMultiple Myeloma

Economic evaluation

Institut Paoli-Calmettes60 participants1 site · FranceCompletes Dec 2015

Compare CT.gov Full analysis →

1–15 of 139,773